Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-effectiveness calculations from trials

E Ambrosioni1, F V Costa

  • 1Clinica Medica III, Policlinico S. Orsola, University of Bologna, Italy.

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|September 1, 1996
PubMed
Summary

Antihypertensive therapy effectiveness data from clinical trials may underestimate real-world results. Future research on newer drugs will improve cost-effectiveness evaluations for hypertension treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High fidelity defines the temporal consistency of host-parasite interactions in a tropical coastal ecosystem.

Scientific reports·2020
Same author

The Importance of Forest Simplification and Litter Disturbance in Defining the Assembly of Ground-Foraging Ants.

Neotropical entomology·2020
Same author

The VO(2)-on kinetics in constant load exercise sub-anaerobic threshold reflects endothelial function and dysfunction in muscle microcirculation.

Physiological research·2015
Same author

Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2014
Same author

The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials?

International journal of clinical practice·2007
Same author

Initial combination therapy with olmesartan/hydrochlorothiazide in moderate-to-severe hypertension.

Journal of human hypertension·2006

Area of Science:

  • Cardiology
  • Health Economics
  • Pharmacology

Background:

  • Large clinical trials provide crucial data on antihypertensive therapy effectiveness.
  • Current data may underestimate the true effectiveness of hypertension treatments.
  • Limitations exist in current cost-effectiveness evaluations of antihypertensive drugs.

Purpose of the Study:

  • To highlight the importance of data from clinical trials for antihypertensive therapy.
  • To address the limitations in current effectiveness and cost-effectiveness evaluations.
  • To emphasize the need for economic evaluation of hypertension morbidity and mortality reduction.

Main Methods:

  • Analysis of data from large-scale clinical trials on antihypertensive therapy.
  • Review of existing literature on the cost-effectiveness of hypertension management.

Related Experiment Videos

  • Discussion of the challenges in valuing life-years gained in public health.

    • Main Results:

    • Clinical trial data, while important, possess flaws that likely lead to underestimation of antihypertensive therapy effectiveness.
    • Emerging data on newer drug classes will enhance future cost-effectiveness analyses.
    • Determining the economic value of preventing hypertension-related morbidity and mortality is a complex societal challenge.

    Conclusions:

    • Accurate assessment of antihypertensive therapy effectiveness requires ongoing evaluation of clinical trial data and newer drug classes.
    • Societies must establish a framework for valuing life-years gained to prioritize hypertension control.
    • Economic evaluations are essential for optimizing public health strategies against hypertension.